{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:01:29Z","timestamp":1790895689943,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2771,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2007.08414.x","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T15:53:31Z","timestamp":1201708411000},"page":"578-586","source":"Crossref","is-referenced-by-count":24,"title":["Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101"],"prefix":"10.1093","volume":"158","author":[{"given":"G.M.","family":"Frei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-M.","family":"Hanschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Albeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sredni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.S.","family":"Schnierle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cncr.10706","article-title":"Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma","volume":"95","author":"Chiarion-Sileni","year":"2002","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0733-8635(18)30176-1","article-title":"Cytogenetic findings in cell lines from cutaneous T-cell lymphoma","volume":"12","author":"Kaltoft","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2004.00201.x","article-title":"Establishment of a mouse xenograft model for mycosis fungoides","volume":"13","author":"Thaler","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S1525-0016(03)00241-7","article-title":"MLV\/HIV-pseudotyped vectors: a new treatment option for cutaneous T cell lymphomas","volume":"8","author":"Thaler","year":"2003","journal-title":"Mol Ther"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/330173a0","article-title":"A new immunomodulating compound (AS-101) with potential therapeutic application","volume":"330","author":"Sredni","year":"1987","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jnci\/88.18.1276","article-title":"Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101","volume":"88","author":"Sredni","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.161.7.3536","article-title":"Up-regulation by ammonium trichloro (dioxoethylene-O,O\u2019) tellurate (AS101) of Fas\/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101","volume":"161","author":"Kalechman","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.bcp.2006.06.015","article-title":"The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt\/survivin pathway","volume":"72","author":"Hayun","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F","article-title":"The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models","volume":"65","author":"Sredni","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00015550152572877","article-title":"Cytokine profile of patients with mycosis fungoides and the immunomodulatory effect of AS101","volume":"81","author":"Shohat","year":"2001","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V55.3.409.409","article-title":"Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas","volume":"55","author":"Gazdar","year":"1980","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02631086","article-title":"Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides","volume":"28A","author":"Kaltoft","year":"1992","journal-title":"In Vitro Cell Dev Biol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1101\/gad.12.11.1551","article-title":"Proteases to die for","volume":"12","author":"Cryns","year":"1998","journal-title":"Genes Dev"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem J"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0014-5793(97)01068-5","article-title":"Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis","volume":"414","author":"Hampton","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0891-5849(00)00302-6","article-title":"Triggering and modulation of apoptosis by oxidative stress","volume":"29","author":"Chandra","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1158\/1078-0432.CCR-04-2273","article-title":"Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species","volume":"11","author":"Nakazato","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/biof.5520140117","article-title":"Selenium and signal transduction: roads to cell death and anti-tumour activity","volume":"14","author":"Ghose","year":"2001","journal-title":"Biofactors"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/cr60090a001","article-title":"The chemistry and toxicity of selenium compounds, with special reference to the selenium problem","volume":"28","author":"Painter","year":"1941","journal-title":"Chem Rev"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB22|cit22","first-page":"333","article-title":"Active oxygen generation as a possible mechanism of selenium toxicity","volume":"10","author":"Seko","year":"1997","journal-title":"Biomed Environ Sci"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0006-2952(93)90080-G","article-title":"Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells","volume":"45","author":"Yan","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0891-5849(94)90007-8","article-title":"On the nature of selenium toxicity and carcinostatic activity","volume":"17","author":"Spallholz","year":"1994","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1096\/fj.03-0552fje","article-title":"Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression","volume":"18","author":"Sredni","year":"2004","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/ic971456t","article-title":"Tellurium compounds: selective inhibition of cysteine proteases and model reaction with thiols","volume":"37","author":"Albeck","year":"1998","journal-title":"Inorg Chem"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1096\/fj.06-7500com","article-title":"Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson\u2019s disease models","volume":"21","author":"Sredni","year":"2007","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1111\/j.1742-4658.2007.05842.x","article-title":"The organotellurium compound ammonium trichloro(dioxoethylene-O,O\u2019) tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice","volume":"274","author":"Okun","year":"2007","journal-title":"FEBS J"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bcp.2007.05.011","article-title":"Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake","volume":"74","author":"Frei","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/hupa.2000.20370","article-title":"Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis","volume":"31","author":"Izban","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"14008","DOI":"10.1074\/jbc.273.22.14008","article-title":"Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates","volume":"273","author":"Giri","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/bbrc.1995.1645","article-title":"Low-level oxidative stress causes cell-cycle specific arrest in cultured cells","volume":"210","author":"Clopton","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1073\/pnas.91.10.4130","article-title":"Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells","volume":"91","author":"Chen","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI200524826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by S\u00e9zary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/1523-1747.ep12330869","article-title":"Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA","volume":"107","author":"Asadullah","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","article-title":"CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides","volume":"32","author":"Hoppe","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/cimm.1997.1087","article-title":"The immunomodulator AS-101 inhibits IL-10 release and augments TNF alpha and IL-1 alpha release by mouse and human mononuclear phagocytes","volume":"176","author":"Strassmann","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood.V85.6.1555.bloodjournal8561555","article-title":"Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro (dioxyethylene-O-O\u2019) tellurate","volume":"85","author":"Kalechman","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2007.08414.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.ASN.0000053415.29636.4F","article-title":"Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101","volume":"14","author":"Kalechman","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.08414.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.08414.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T05:12:17Z","timestamp":1684213937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/158\/3\/578\/6643803"}},"subtitle":["AS101 and mycosis fungoides"],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":43,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08414.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,30]]}}}